Javascript must be enabled to continue!
In-vivo Pharmacokinetics of δ-ALA induced PPIX during Photodynamic Therapy on mice tumor model
View through CrossRef
In the recent years δ-aminolevulinic acid (δ-ALA) a precursor for the endogenous production of protoporphyrin IX (PPIX) has gained importance in the Photodynamic Therapy (PDT) of superficial and early-stage cancers. Though δ-ALA is present naturally in the cells, systemic administration of exogenous δ-ALA leads to the production of intracellular endogenous PP IX in both the tumor and the normal cells, but with varying concentration. However, the PPIX is accumulated more in the tumor tissues as the fast growing tumor cells take up the administered δ-ALA more than the normal cells. As the therapeutic efficacy of PDT is dependent on the post δ-ALA incubation time, at which the tumor to normal ratio of the PPIX concentration is high, the concentration of the PPIX in the normal and the tumor site were estimated using fluorescence spectroscopy. However, the estimation of the PPIX concentration during/after PDT is mandatory, as the PDT dosimetry is dependent on the sensitizer concentration at the target of interest. The observed variation in the concentration of PPIX in the tumor site with respect to the unexposed normal surrounding tissues, may be attributed to the diffusion of PPIX from the surrounding normal tissues to the tumor site, across the concentration gradient. Based on this a mathematical model has been proposed, to estimate the rate parameter for the diffusion of PPIX from the surrounding normal tissues in to the tumor tissue (Km), due to photobleaching during PDT at two different fluence. The Km value at two different fluences, 57.6 and 36 J/cm2 are estimated as 5.444 ± 1.186 and 3.221 ± 0.957, respectively. Further, the rate parameter for the cleavage and efflux of δ-ALA (Kl), and the rate parameter for the evasion of the PPIX from the tumor tissues during PDT (Kt), were also estimated by fitting the experimental data to the developed mathematical model. The estimated parameters will be utilized to estimate the exact concentration of PPIX in the tumor tissues for a better PDT efficacy.
Title: In-vivo Pharmacokinetics of δ-ALA induced PPIX during Photodynamic Therapy on mice tumor model
Description:
In the recent years δ-aminolevulinic acid (δ-ALA) a precursor for the endogenous production of protoporphyrin IX (PPIX) has gained importance in the Photodynamic Therapy (PDT) of superficial and early-stage cancers.
Though δ-ALA is present naturally in the cells, systemic administration of exogenous δ-ALA leads to the production of intracellular endogenous PP IX in both the tumor and the normal cells, but with varying concentration.
However, the PPIX is accumulated more in the tumor tissues as the fast growing tumor cells take up the administered δ-ALA more than the normal cells.
As the therapeutic efficacy of PDT is dependent on the post δ-ALA incubation time, at which the tumor to normal ratio of the PPIX concentration is high, the concentration of the PPIX in the normal and the tumor site were estimated using fluorescence spectroscopy.
However, the estimation of the PPIX concentration during/after PDT is mandatory, as the PDT dosimetry is dependent on the sensitizer concentration at the target of interest.
The observed variation in the concentration of PPIX in the tumor site with respect to the unexposed normal surrounding tissues, may be attributed to the diffusion of PPIX from the surrounding normal tissues to the tumor site, across the concentration gradient.
Based on this a mathematical model has been proposed, to estimate the rate parameter for the diffusion of PPIX from the surrounding normal tissues in to the tumor tissue (Km), due to photobleaching during PDT at two different fluence.
The Km value at two different fluences, 57.
6 and 36 J/cm2 are estimated as 5.
444 ± 1.
186 and 3.
221 ± 0.
957, respectively.
Further, the rate parameter for the cleavage and efflux of δ-ALA (Kl), and the rate parameter for the evasion of the PPIX from the tumor tissues during PDT (Kt), were also estimated by fitting the experimental data to the developed mathematical model.
The estimated parameters will be utilized to estimate the exact concentration of PPIX in the tumor tissues for a better PDT efficacy.
Related Results
GW24-e0089 Apoptosis of THP-1 macrophages induced by protoporphyrin IX mediated sonodynamic therapy
GW24-e0089 Apoptosis of THP-1 macrophages induced by protoporphyrin IX mediated sonodynamic therapy
Objectives
Sonodynamic therapy (SDT) was developed as a localised ultrasound-activated cytotoxic therapy for cancers. The ability of SDT to destroy target tissues...
Determination of aminolevulinic-acid-induced protoporphyrin IX in mice skin
Determination of aminolevulinic-acid-induced protoporphyrin IX in mice skin
The kinetics of Protoporphyrin IX (PpIX) production in mice skin was studied by photoacoustic spectroscopy. PpIX was induced in mice by intraperitoneal administration of δ-aminolev...
Fluorescence-Guided Resection of Malignant Glioma with 5-ALA
Fluorescence-Guided Resection of Malignant Glioma with 5-ALA
Malignant gliomas are extremely difficult to treat with no specific curative treatment. On the other hand, photodynamic medicine represents a promising technique for neurosurgeons ...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
10th Annual Meeting, 25‐26 November 1976, Adelaide 1. Histamine metabolism in aortae of two histamine sensitive species. A. Foldes, M. J. Stacey and I. S. de la Lande 2. Localizat...
GW24-e2259 Evaluation of atherosclerosis in low density lipoprotein receptor defect mice by ultrasound biomicroscopy
GW24-e2259 Evaluation of atherosclerosis in low density lipoprotein receptor defect mice by ultrasound biomicroscopy
Objectives
Low density lipoprotein receptor defect mice model by transgenetic technology was used to detect atherosclerosis by Ultrasound Biology (UBM). And evalu...
Fluorescence-Enhanced Photodynamic Assessments for Human Breast Cancer Cell Characterizations
Fluorescence-Enhanced Photodynamic Assessments for Human Breast Cancer Cell Characterizations
Even with 100% certainty of a complete cure for breast cancer (BC), there is still a long way to go toward more efficient treatment. This requires sensitive and timely detection an...
Cell-surface photochemistry mediated calcium overload for synergistic tumor therapy
Cell-surface photochemistry mediated calcium overload for synergistic tumor therapy
Abstract
Calcium (Ca2+) is essential for mitochondrial homeostasis and function coordination, particularly in cancer cells that metabolize frequently to sustain their growt...
Abstract P6-10-02: Self-assembled nano drugs of pyrotinib and indocyanine green based on photothermal photodynamic therapy
Abstract P6-10-02: Self-assembled nano drugs of pyrotinib and indocyanine green based on photothermal photodynamic therapy
Abstract
Background: Photothermal and photodynamic therapy is a new tumor treatment strategy, which can kill tumor cells and reduce the damage to surrounding normal ...

